| 6150557 |
Compounds |
Jerry L. Adams, Peter Sheldrake, Timothy Francis Gallagher, Ravi Shanker Garigipati, Jeffrey C. Boehm +3 more |
2000-11-21 |
$37,221,000 |
| 6103936 |
Process of making tosylbenzyl formamide derivatives |
Jerry L. Adams, Peter Sheldrake, Timothy Francis Gallagher, Ravishanker Garigipati, Jeffrey C. Boehm +3 more |
2000-08-15 |
$38,964,000 |
| 5990119 |
1,4,4-(trisubstituted)cyclohexane monomers and related compounds |
Siegfried B. Christensen, IV, Joseph M. Karpinski, M. Dominic Ryan |
1999-11-23 |
$18,763,000 |
| 5977122 |
4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds |
Siegfried B. Christensen, IV, Joseph M. Karpinski, M. Dominic Ryan |
1999-11-02 |
$16,883,000 |
| 5969184 |
Amide compounds |
Jerry L. Adams, Peter Sheldrake, Timothy Francis Gallagher, Ravi Shanker Garigipati, Jeffrey C. Boehm +3 more |
1999-10-19 |
$12,184,000 |
| 5948777 |
Cannabinoid receptor agonists |
Siegfried B. Christensen, IV |
1999-09-07 |
$15,641,000 |
| 5900417 |
1,3,3-(Trisubstituted)cyclohexanemonomers and related compounds |
Siegfried B. Christensen, IV, Joseph M. Karpinski, M. Dominic Ryan |
1999-05-04 |
$38,789,000 |
| 5892098 |
3,3-(disubstituted)cyclohexan-1-one monomers and related compounds |
Siegfried B. Christensen, IV, Joseph M. Karpinski, M. Dominic Ryan |
1999-04-06 |
$20,165,000 |
| 5891883 |
4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds |
Siegfried B. Christensen, IV, Joseph M. Karpinski, M. Dominic Ryan |
1999-04-06 |
$20,165,000 |
| 5869677 |
3,3-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds |
Siegfried B. Christensen, IV, Joseph M. Karpinski, M. Dominic Ryan |
1999-02-09 |
$18,638,000 |
| 5866616 |
3,3-(disubstituted) cyclohexan-1-ol monomers and related compounds |
Siegfried B. Christensen, IV, Joseph M. Karpinski, M. Dominic Ryan |
1999-02-02 |
$10,934,000 |
| 5863926 |
4,4-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds |
Siegfried B. Christensen, IV, Joseph M. Karpinski, M. Dominic Ryan |
1999-01-26 |
$21,927,000 |
| 5861421 |
4,4-(disubstituted) cyclohexan-1-one monomers and related compounds |
Siegfried B. Christensen, IV, Joseph M. Karpinski, M. Dominic Ryan |
1999-01-19 |
$35,297,000 |
| 5811455 |
Compounds useful for treating allergic or inflammatory diseases |
Siegfried B. Christensen, IV, Cornelia Forster |
1998-09-22 |
$18,983,000 |
| 5646158 |
1,3,3-(trisubstituted)cyclohex-1-ene monomers and related compounds |
Siegfried B. Christensen, IV, Joseph M. Karpinski, M. Dominic Ryan |
1997-07-08 |
$42,004,000 |
| 5631286 |
Compounds useful for treating allergic or inflammatory diseases |
Siegfried B. Christensen, IV, Cornelia Forster |
1997-05-20 |
$21,953,000 |
| 5449686 |
Compounds useful for treating allergic or inflammatory diseases |
Siegfried B. Christensen, IV, Cornelia Forster |
1995-09-12 |
$413,000 |
| 5449687 |
4-phenyl-1,2-cyclohexyl derivatives and anti-inflammatory compositions and methods thereof |
Siegfried B. Christensen, IV, Cornelia Forster, John G. Gleason |
1995-09-12 |
$413,000 |
| 5393788 |
Phenylalkyl oxamides |
Siegfried B. Christensen, IV, Klaus M. Esser, Cornelia Forster, Michael D. Ryan, Philip L. Simon |
1995-02-28 |
$291,000 |
| 5317019 |
Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages |
Don Edgar Griswold, Nabil Hanna, John Lee, Bartholomew Votta, Philip L. Simon +2 more |
1994-05-31 |
$502,000 |
| 5145858 |
Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors |
Jerry L. Adams, John G. Gleason, Nabil Hanna, John F. Newton, Carl D. Perchonock |
1992-09-08 |
$491,000 |
| 5134150 |
Inhibition of the 5-lipoxygenase pathway |
John G. Gleason, Don Edgar Griswold, Nabil Hanna, Ivan Lantos, Kazys A. Razgaitis +2 more |
1992-07-28 |
$470,000 |
| 5008390 |
Compounds for preparing 6-phenyl-2,3-dihydroimidazo[2,1-b]-thiazoles and corresponding thiazines |
Ivan Lantos, Michael A. McGuire, Lendon N. Pridgen, Herbert B. Winicov |
1991-04-16 |
|
| 5002941 |
Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors |
Jerry L. Adams, John G. Gleason, Nabil Hanna, John F. Newton, Carl D. Perchonock +1 more |
1991-03-26 |
$410,000 |
| 4847270 |
Inhibition of the 5-lipoxygenase pathway utilizing certain 2,2'-alkyldiyl bis(thio)bis-imidazoles and derivatives |
David T. Hill |
1989-07-11 |
$16,789,000 |